News | Mammography | January 12, 2016

Study determines women in their 40s most likely to experience false-positives

breast cancer screening, digital mammography, false positives, younger women, clinicl study, Annals of Internal Medicine

January 12, 2016 — False-positive results and additional imaging are common among younger women and women with risk factors for breast cancer who are screened with digital mammography. Biopsy occurs less often and rates of false-negative screening results are low. The analysis is published in Annals of Internal Medicine and was used to inform updated clinical practice recommendations from the U.S. Preventive Services Task Force (USPSTF).

Clinical guidelines recommend a personalized approach to mammography screening that takes into account individual risk factors for breast cancer, as well as the potential benefits and harms of screening. Researchers used registry data for more than 400,000 women aged 40 to 89 to estimate rates of false-positive and false-negative digital mammography results — and subsequent imaging and biopsies — among a general population of women undergoing screening with digital mammography. They found that false-positives and recommendations for additional imaging were highest among younger women (those aged 40 to 49 years). These rates decreased with age. Rates of false-negative results were generally low. Risk factors for breast cancer, such as positive family history, previous biopsy, high breast density and low body mass index for younger women, were associated with higher risk for false-positive result.

For more information: www.annals.org


Related Content

News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
Subscribe Now